Life after cancer: a medicine eased the deep tiredness of blood cancers

If you or someone you love lives with a blood cancer, here is good news about life after cancer. A medicine eased the heavy tiredness so many people describe, and it did so better than a look-alike pill.

In a trial of 152 adults with blood cancers, methylphenidate reduced fatigue more than a placebo. Fatigue is the problem people with these cancers name most often, and it is the one that most often goes unaddressed. Now there is a treatment with solid proof behind it.

How the study worked

Researchers recruited 152 adults with a blood cancer and a lot of fatigue. Blood cancers include leukemia, lymphoma and myeloma. Each person took methylphenidate for 6 weeks and a placebo for 6 weeks, in random order, with a treatment-free week in between. Neither the patients nor the doctors knew which pill was which. The results were published Oct. 30, 2026, in the Journal of Clinical Oncology. Each treatment period lasted 6 weeks, and people who had chemotherapy in the previous 8 weeks were not included.

Fatigue was measured with a questionnaire called FACIT-F. Higher scores mean less fatigue.

What they found

Scores improved by about 9 points after methylphenidate, and by about 4 points after the placebo. The exact figures were 8.9 points and 3.9 points. The gap between the two was 5.0 points in favor of methylphenidate.

Other fatigue questionnaires pointed the same way. Each person took both the medicine and the placebo, so each served as their own comparison. That is one reason this kind of design is so convincing.

Side effects were mild. They were reported more often during the methylphenidate periods, 57% of them, than during the placebo periods, 40%. In plain words: the medicine brings a few more minor complaints, and it also brings relief from the tiredness.

Why does this tiredness matter so much?

Cancer-related fatigue is not the kind of tired that a good night’s sleep fixes. It can affect work, family life and mood. Until now, few treatments for it have had strong evidence behind them.

Methylphenidate is a well-known prescription stimulant. It gives the brain a push. This trial shows it can help people who live with blood cancers feel less worn out.

What you can do today

Start by putting a number on the tiredness. Today, rate your fatigue from 0 to 10 and write it down. Do the same each day for a week. Bring the notes to your next oncology visit and tell the team that fatigue is getting in the way of your life. A clear record makes that conversation easy and shows the team exactly what you need help with.

Methylphenidate needs a prescription and medical follow-up, so it is something to talk through with your own team. Your notes are a strong first step.